[Safety and efficacy of the use of eltrombopag in a case of severe acquired bone marrow aplasia]

An Pediatr (Engl Ed). 2019 Apr;90(4):246-247. doi: 10.1016/j.anpedi.2018.04.011. Epub 2018 May 22.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Aplastic / drug therapy*
  • Anemia, Aplastic / pathology
  • Benzoates / adverse effects
  • Benzoates / therapeutic use*
  • Child
  • Female
  • Humans
  • Hydrazines / adverse effects
  • Hydrazines / therapeutic use*
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Severity of Illness Index

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag